S Asif, E Baxevanidi, A Hill, WDF Venter,
L Fairlie… - Aids, 2021 - journals.lww.com
Objective: Integrase inhibitors, including dolutegravir (DTG), are associated with weight gain
and obesity, especially when combined with tenofovir alafenamide (TAF). Obesity increases …